215 related articles for article (PubMed ID: 38276283)
1. Cutaneous Hyalohyphomycosis and Its Atypical Clinical Presentations in Immunosuppressed Patients.
Ferara N; Špoljar S; Lugović-Mihić L; Gverić Grginić A; Rezo Vranješ V; Bešlić I; Perović J; Regović Džombeta T
Life (Basel); 2024 Jan; 14(1):. PubMed ID: 38276283
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous infection caused by Purpureocillium lilacinum: Case reports and literature review of infections by Purpureocillium and Paecilomyces in Taiwan.
Lu KL; Wang YH; Ting SW; Sun PL
J Dermatol; 2023 Aug; 50(8):1088-1092. PubMed ID: 37082787
[TBL] [Abstract][Full Text] [Related]
3. ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others.
Tortorano AM; Richardson M; Roilides E; van Diepeningen A; Caira M; Munoz P; Johnson E; Meletiadis J; Pana ZD; Lackner M; Verweij P; Freiberger T; Cornely OA; Arikan-Akdagli S; Dannaoui E; Groll AH; Lagrou K; Chakrabarti A; Lanternier F; Pagano L; Skiada A; Akova M; Arendrup MC; Boekhout T; Chowdhary A; Cuenca-Estrella M; Guinea J; Guarro J; de Hoog S; Hope W; Kathuria S; Lortholary O; Meis JF; Ullmann AJ; Petrikkos G; Lass-Flörl C; ;
Clin Microbiol Infect; 2014 Apr; 20 Suppl 3():27-46. PubMed ID: 24548001
[TBL] [Abstract][Full Text] [Related]
4. Recurrent cutaneous hyalohyphomycosis secondary to Purpureocillium lilacinum in an immunocompetent individual.
McGeachie DL; Boyce AE; Miller RM
Australas J Dermatol; 2021 Aug; 62(3):e411-e413. PubMed ID: 34170516
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous hyalohyphomycosis caused by Purpureocillium lilacinum in an immunocompetent patient: case report and review.
Saghrouni F; Saidi W; Ben Said Z; Gheith S; Ben Said M; Ranque S; Denguezli M
Med Mycol; 2013 Aug; 51(6):664-8. PubMed ID: 23330674
[TBL] [Abstract][Full Text] [Related]
6. An unusual case of hyalohyphomycosis due to
Raghavan R; Chithra G; Fernandez S; Shamana Suryanarayana B; Singh R
Curr Med Mycol; 2018 Jun; 4(2):36-39. PubMed ID: 30324156
[TBL] [Abstract][Full Text] [Related]
7. Non-
Jacobs SE; Walsh TJ
J Fungi (Basel); 2023 Feb; 9(2):. PubMed ID: 36836326
[TBL] [Abstract][Full Text] [Related]
8. Non-Aspergillus Hyaline Molds: Emerging Causes of Sino-Pulmonary Fungal Infections and Other Invasive Mycoses.
Jacobs SE; Wengenack NL; Walsh TJ
Semin Respir Crit Care Med; 2020 Feb; 41(1):115-130. PubMed ID: 32000288
[TBL] [Abstract][Full Text] [Related]
9. Experimental Hyalohyphomycosis by
de Sequeira DCM; Menezes RC; Oliveira MME; Antas PRZ; De Luca PM; de Oliveira-Ferreira J; Borba CM
Front Microbiol; 2017; 8():1617. PubMed ID: 28878763
[No Abstract] [Full Text] [Related]
10. Detection of antibody to Purpureocillium lilacinum by immunofluorescent assay and flow cytometry in serum of infected C57BL/6 mice.
de Sequeira DC; Peixoto ML; De Luca PM; Oliveira-Ferreira J; Antas PR; Borba CM
J Immunol Methods; 2013 Oct; 396(1-2):147-51. PubMed ID: 23872615
[TBL] [Abstract][Full Text] [Related]
11. Purpureocillium lilacinum an emergent pathogen: antifungal susceptibility of environmental and clinical strains.
Corrêa-Moreira D; de Lima Neto RG; da Costa GL; de Moraes Borba C; Oliveira MME
Lett Appl Microbiol; 2022 Jul; 75(1):45-50. PubMed ID: 35342967
[TBL] [Abstract][Full Text] [Related]
12. First reported case of subcutaneous hyalohyphomycosis caused by Paecilomyces variotii.
Vasudevan B; Hazra N; Verma R; Srinivas V; Vijendran P; Badad A
Int J Dermatol; 2013 Jun; 52(6):711-3. PubMed ID: 23679876
[TBL] [Abstract][Full Text] [Related]
13. Fatal hyalohyphomycosis with cutaneous involvement caused by Purpureocillium lilacinum in an immunocompromised patient with bullous pemphigoid.
Corbeddu M; Ferreli C; Cappai R; Ferraguti P; Atzori L; Pilloni L; Rongioletti F
Acta Biomed; 2021 Jul; 92(3):e2021139. PubMed ID: 34212928
[TBL] [Abstract][Full Text] [Related]
14. Skin Immune Response of Immunocompetent and Immunosuppressed C57BL/6 Mice After Experimental Subcutaneous Infection Caused by
Corrêa-Moreira D; Dos Santos A; Menezes RC; Morgado FN; Borba CM; Oliveira-Ferreira J
Front Microbiol; 2021; 12():615383. PubMed ID: 34194400
[TBL] [Abstract][Full Text] [Related]
15. Acremonium species: a review of the etiological agents of emerging hyalohyphomycosis.
Das S; Saha R; Dar SA; Ramachandran VG
Mycopathologia; 2010 Dec; 170(6):361-75. PubMed ID: 20577905
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and therapeutic challenges of treating opportunistic fungal cellulitis: a case series.
Paul J; Czech MM; Balijepally R; Brown JW
BMC Infect Dis; 2022 May; 22(1):435. PubMed ID: 35513796
[TBL] [Abstract][Full Text] [Related]
17. Hyphae, pseudohyphae, yeasts, spherules, spores, and more: A review on the morphology and pathology of fungal and oomycete infections in the skin of domestic animals.
Rodrigues Hoffmann A; Ramos MG; Walker RT; Stranahan LW
Vet Pathol; 2023 Nov; 60(6):812-828. PubMed ID: 37222139
[TBL] [Abstract][Full Text] [Related]
18. Localized cutaneous infection caused by Scedosporium apiospermum: Report of a case diagnosed on cytology.
Agarwal R; Singh M; Chawla R; Kumar GD; Mishra A; Jain S
Diagn Cytopathol; 2021 Apr; 49(4):E187-E189. PubMed ID: 33074579
[TBL] [Abstract][Full Text] [Related]
19. Localized Cutaneous Hyalohyphomycosis by
Rajput CD; Lilani S; Paradeshi K; Deore VS
Indian Dermatol Online J; 2019; 10(3):307-310. PubMed ID: 31149579
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of antifungal- and cryotherapy-resistant subcutaneous hyalohyphomycosis in an immunocompetent case with topical 5% imiquimod cream.
Erbagci Z; Tuncel AA; Erkilic S; Zer Y
Mycopathologia; 2005 Jun; 159(4):521-6. PubMed ID: 15983738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
